Provides software that analyzes heart scans to help physicians diagnose and manage coronary artery disease.
10-K for FY2025, filed Mar 18, 2026
Medical providers are charged each time a physician orders an FFRCT or Plaque Analysis, and Heartflow bills when the analysis is delivered. Some contracts instead charge a fixed amount upfront for unlimited analyses over the contract term.
10-K for FY2025, filed Mar 18, 2026
$176M
10-K for FY2025, filed Mar 18, 2026
$176M ↗
Heartflow sells directly to medical providers in the United States and has small direct commercial teams in the United Kingdom, Japan and other European Union countries. Its platform is used at hospitals and outpatient imaging facilities.
10-K for FY2025, filed Mar 18, 2026We market and sell our Heartflow Platform in the United States through a direct sales organization. We have developed a highly scalable…View ↗
We also have small, direct commercial teams in the United Kingdom, Japan and other countries in the European Union. We may continue to…View ↗
When a patient presents with symptoms of CAD and their physician follows the AHA and ACC Class 1, Level A chest pain guidelines by…View ↗
No. It lost $116.8M in FY2025.
10-Q for Q3 FY2026, filed Nov 12, 2026
−$11.5MView ↗
8-K, filed Nov 12, 2026
Total revenue of $262 million to $264 million (approximately 49% to 50% growth year-over-year), compared to previous guidance of $246…View ↗
Competes with Siemens Healthineers, GE Healthcare, Koninklijke Philips, Canon Medical Systems, Cleerly, Elucid Bioimaging, and Keya Medical Technology
10-K for FY2025, filed Mar 18, 2026We consider our primary competition to be traditional non-invasive tests for CAD including primarily stress tests such as SPECT, stress…View ↗
Loading...